Risk factors for primary graft dysfunction after lung transplantation

Area of Science:

• Thoracic Surgery
• Transplantation Medicine
• Pulmonary Medicine

Background:

• Primary graft dysfunction (PGD) is a major cause of early morbidity and mortality after lung transplantation.
• The International Society for Heart and Lung Transplantation (ISHLT) developed a grading system for PGD based on oxygenation levels within 48 hours post-transplant.
• Higher ISHLT grades of PGD correlate with worse outcomes, including increased operative mortality and reduced long-term survival.

Purpose of the Study:

• To identify specific donor and recipient risk factors associated with severe primary graft dysfunction (ISHLT grade 3) following lung transplantation.
• To inform strategies for mitigating reperfusion injury and improving post-transplant outcomes.

Main Methods:

• Retrospective review of medical records from 402 lung transplantations performed between 1992 and 2004.
• Calculation of the worst ISHLT PGD grade within the first 48 hours postoperatively.
• Bivariate and multivariate analyses were used to examine associations between potential risk factors and ISHLT grade 3 PGD (defined as arterial to fraction of inspired oxygen ratio < 200).

Main Results:

• The 90-day mortality rate was 17% for patients with ISHLT grade 3 PGD versus 9% for those without.
• Bivariate analysis identified donor age, donor smoking history, early transplantation era (1992-1998), recipient pulmonary artery pressure, and recipient diagnosis as significant risk factors.
• Multivariate analysis revealed that recipient pulmonary artery pressure, donor age, and transplantation era were independently associated with grade 3 PGD (P < .05).

Conclusions:

• Recipient pulmonary artery pressure, donor age, and the transplantation era are significant predictors of severe primary graft dysfunction after lung transplantation.
• Identification of these high-risk factors allows for targeted interventions to reduce reperfusion injury.
• These findings aid in stratifying patients at risk for poor outcomes, potentially improving lung transplant success rates.